D-1428-2012 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-1428-2012 was initiated by Zydus Pharmaceuticals USA Inc on Mar 14, 2012 and is designated Class II. Reason for recall: Presence of Foreign Substance(s): A product complaint was received from a pharmacist who discovered that several tablets displayed brown specks. The same complainant also reported that metal shaving… The recall status is terminated (terminated Dec 17, 2013). Affected quantity: 1176 Bottles.

Recall details

Product Type
Drugs
Report Date
Aug 8, 2012
Initiation Date
Mar 14, 2012
Termination Date
Dec 17, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1176 Bottles

Product description

Metformin Hydrochloride Tablets, USP, 1000 mg, Rx only, 1000 count tablets per Bottle, Manufactured by: Cadila Healthcare LTD. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-030-10.

Reason for recall

Presence of Foreign Substance(s): A product complaint was received from a pharmacist who discovered that several tablets displayed brown specks. The same complainant also reported that metal shaving like material was observed on the surface of one tablet.

Distribution pattern

Nationwide

Code information

Lot #: ML9605 Exp. 10/2013

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1428-2012
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1428-2012. Report a data issue: hello@regdatalab.com.